A Mathematical Model of Cell Cycle Progression Applied to the MCF-7 Breast Cancer Cell Line

被引:0
|
作者
Kate Simms
Nigel Bean
Adrian Koerber
机构
[1] University of Adelaide,Applied Mathematics
来源
关键词
Cell cycle; Mathematical model;
D O I
暂无
中图分类号
学科分类号
摘要
In this paper, we present a model of cell cycle progression and apply it to cells of the MCF-7 breast cancer cell line. We consider cells existing in the three typical cell cycle phases determined using flow cytometry: the G1, S, and G2/M phases. We further break each phase up into model phases in order to capture certain features such as cells remaining in phases for a minimum amount of time. The model is also able to capture the environmentally responsive part of the G1 phase, allowing for quantification of the number of environmentally responsive cells at each point in time. The model parameters are carefully chosen using data from various sources in the biological literature. The model is then validated against a variety of experiments, and the excellent fit with experimental results allows for insight into the mechanisms that influence observed biological phenomena. In particular, the model is used to question the common assumption that a ‘slow cycling population’ is necessary to explain some results. Finally, an extension is proposed, where cell death is included in order to accurately model the effects of tamoxifen, a common first line anticancer drug in breast cancer patients. We conclude that the model has strong potential to be used as an aid in future experiments to gain further insight into cell cycle progression and cell death.
引用
收藏
页码:736 / 767
页数:31
相关论文
共 50 条
  • [21] Preventing chemoresistance of human breast cancer cell line, MCF-7 with celecoxib
    Chen, Chen
    Shen, Hui Ling
    Yang, Jing
    Chen, Qiao Yun
    Xu, Wen Lin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (01) : 9 - 17
  • [22] MCF-7: The first hormone-responsive breast cancer cell line
    Levenson, AS
    Jordan, VC
    CANCER RESEARCH, 1997, 57 (15) : 3071 - 3078
  • [23] HETEROGENEITY OF THE HUMAN-BREAST CANCER CELL-LINE MCF-7
    BUTLER, B
    BERLINSKI, PJ
    KELSEY, WH
    TOENNIGES, MM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 236 - 236
  • [24] Proteomic analysis of MCF-7 breast cancer cell line exposed to leptin
    Valle, A.
    Sastre-Serra, J.
    Pol, C.
    Miro, A. M.
    Oliver, J.
    Roca, P.
    ANALYTICAL CELLULAR PATHOLOGY, 2011, 34 (03) : 147 - 157
  • [25] Identification of DNA palindromes in the MCF-7 breast cancer cell line.
    Yang, Hui
    Volfovsky, Natalia
    Rattray, Alison
    Chen, Xiongfong
    Tanaka, Hisashi
    Jeffrey, Strathern
    CANCER RESEARCH, 2013, 73 (08)
  • [26] Inhibition of cell proliferation by siRNA targeting hPRLR in breast cancer MCF-7 cell line
    Mei Pan a△
    b Department of Oncology
    Journal of Nanjing Medical University, 2007, (06) : 372 - 376
  • [27] Multiple mechanisms of cell death induced by chelidonine in MCF-7 breast cancer cell line
    Noureini, Sakineh Kazemi
    Esmaili, Hosein
    CHEMICO-BIOLOGICAL INTERACTIONS, 2014, 223 : 141 - 149
  • [28] Multiparametric flow cytometric analysis in a breast cancer cell line (MCF-7)
    Lee, GSR
    Ryu, KS
    Rha, JG
    Kim, SP
    Namkoong, SE
    Han, KT
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2002, 28 (03) : 141 - 148
  • [29] Preventing chemoresistance of human breast cancer cell line, MCF-7 with celecoxib
    Chen Chen
    Hui Ling Shen
    Jing Yang
    Qiao Yun Chen
    Wen Lin Xu
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 9 - 17
  • [30] Vitamin D - Metabolism in the human breast cancer cell line MCF-7
    Diesing, Dagmar
    Cordes, Tim
    Fischer, Dorothea
    Diedrich, Klaus
    Friedrich, Michael
    ANTICANCER RESEARCH, 2006, 26 (4A) : 2755 - 2759